MINI REVIEW
Promising findings from the ECHO trial suggest that integrating acalabrutinib with standard therapy could set a new standard for frontline treatment in older/unfit MCL patients.
This mini-review summarizes the recent results of the phase II PALOMA study and the phase III MARIPOSA trial.
This article aims to explore the available data, as well as emerging approaches to biomarker analysis that may help to determine the optimal duration of IO treatment for NSCLC patients.
This paper highlights diagnostic challenges in the classification and risk stratification of patients with clonal hematopoiesis and myelodysplastic neoplasms, dysregulation of immune hemostasis and its impact on degenerative-inflammatory comorbidities.
This paper focuses on recent data demonstrating the benefits of GA and GA-driven interventions on clinical outcomes of geriatric patients with cancer.
This article provides an overview of the complexities in the treatment of patients with HCC.
This review summarizes recent trials evaluating PARP inhibitors, as well as discusses remaining therapeutic challenges such as drug resistance and the quest for novel predictive biomarkers in ovarian cancer.
This article discusses the current diagnostic challenges and therapy options for systemic amyloidosis and summarizes the activities of the Swiss Amyloidosis Network (SAN).
This article summarizes current challenges in prostate cancer management and recent updates in treatment strategies.
The article delves into the current controversies surrounding surgical approaches to prostatectomy and the challenges in educating urology residents.